Birmingham, West Midlands -- (SBWIRE) -- 12/05/2013 -- Value Penny Stocks issues special report on Dynavax Technologies Corporation (NASDAQ:DVAX), RF Micro Devices, Inc. (NASDAQ:RFMD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Janus Capital Group Inc (NYSE:JNS).
Dynavax Technologies Corporation (NASDAQ:DVAX) opened its last trade at the price of $1.76. Its closing price was $1.73 after losing 1.73% for the day. The company traded with the total volume of 3,071,350 shares, while its average trading volume remained 5.27 million shares. The beta of this stock stands at 2.75. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences.
Has DVAX Found The Bottom and Ready To Move Up? Find Out Here
RF Micro Devices, Inc. (NASDAQ:RFMD) percentage change surged 0.96% to close at $5.26 with the total traded volume of 2,997,334 shares, along with average volume of 4.95 million shares. The 52 week range of the stock remained $4.25 - $6.20, while its day lowest price was $5.17. The share price hit the day highest price of $5.29. RF Micro Devices, Inc. engages in the design, development, manufacture, and marketing of radio frequency (RF) solutions for original equipment manufacturers and original design manufacturers in wireless and wired communications applications in the United States and internationally.
For How Long RFMD’s Gloss will Attract Investors? Find out via this report
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) traded on volume of 2,930,373 shares in the last session against average volume of 2.30 million shares. The company started its trading session with the price of $3.24 and closed at $3.42 by scoring +4.91%. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection.
Will ACHN Continue To Move Higher? Find Out Here
Janus Capital Group Inc (NYSE:JNS) started its last trading session with the price of $10.56 and closed at $10.82 by scoring +2.37%. The stock traded with total volume of 2,860,248 shares, while the average trading volume remained 2.78 million shares. The beta value of this stock stands at 2.66. Day range for the stock was $10.52 - $10.92. Janus Capital Group, Inc. is a publicly owned asset management holding company with approximately $167.7 billion in assets under management. It also provides retirement planning, investment planning, tax planning, investment for college, and tax planning services to its clients.
Why Should Investors Buy JNS After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)